Lotus Pharm vs Ever Supreme Bio Technology: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Ever Supreme Bio Technology (6712) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Ever Supreme Bio Technology

0%+226%-22%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYEver Supreme Bio TechnologyYoY
Oct 2026NT$2.13 billion-22.5%NT$112.1 million+0.8%
Sep 2026NT$2.77 billion+128.0%NT$110.5 million+21.3%
Aug 2026NT$2.11 billion+81.7%NT$109.6 million+21.1%
Jul 2026NT$2.49 billion+3.9%NT$99.2 million+20.7%
Jun 2026NT$3.4 billion+225.5%NT$93.9 million+16.1%
May 2026NT$2.32 billion+105.8%NT$90.6 million+25.0%
Apr 2026NT$3.09 billion+19.9%NT$85.2 million+26.2%
Mar 2026NT$4.35 billion+173.6%NT$70.1 million+15.1%
Feb 2026NT$2.24 billion+131.5%NT$62.2 million+3.4%
Jan 2026NT$2.05 billion-5.5%NT$58.2 million+2.4%
Dec 2025NT$2.44 billion+66.9%NT$128 million+0.7%
Nov 2025NT$1.06 billion-0.2%NT$125 million+1.3%
Oct 2025NT$2.75 billion+46.0%NT$111.1 million+12.2%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16